DOCSLIB.ORG

Table S1. Database for the Targeted Analysis. Name Other Name

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table S1. Database for the Targeted Analysis. Name Other Name Table S1. Database for the targeted analysis. Molecular Exact monoisotopic Name Other name References Formula mass 2-O-β-glucopyranose-2-hydroxy-4-methoxyhydrocinnamic 2-Hydroxy-4-methoxyhydrocinnamoyl-2-O- [25] C16H22O9 358.1264 acid glucoside [17,23] 5-geranoxy-7-methoxycoumarin C20H24O4 328.1675 [9,23] 5-Sinapoylquinic acid C18H22O10 398.1213 [9,15,17-21,23-25] Apigenin 6,8 di C-glucoside Vicenin-2 C27H30O15 594.1585 [18-19,21,25] Apigenin 6-C-glucoside C21H20O10 432.1056 [23] Apigenin 7-O- diglucuronide C27H26O17 622.1170 [15-16,18-19,21,23-25] Apigenin 7-O-neohesperidoside Rhoifolin C27H30O14 578.1636 [15,18-19,23] Apigenin 7-O-neohesperidoside-4′-glucoside Rhoifolin 4'-glucoside C33H40O19 740.2164 [17] Apigenin monorhamnoside C21H20O9 416.1107 [16,24] Apigenin-7-O-neohesperidoside-6''-O-HMG C33H38O18 722.2058 [9,21,25] Apigenin-8-C-glucoside C21H20O10 432.1056 [16] Apigenin C15H10O5 270.0528 [9,25] Bergamjuicin C39H50O23 886.2743 [17-18,21,23,25] Bergamottin C21H22O4 338.1518 [9,17-18,21,23,25] Bergapten C12H8O4 216.0423 [9,15-16,20-25] Brutieridin C34H42O19 754.2320 [16] Chrysoeriol C16H12O6 300.0634 [18-19,21,25] Chrysoeriol 6,8-di-C-glucoside Stellarin-2 C28H32O16 624.1690 [9,18-21] Chrysoeriol 7-O-neohesperidoside C28H32O15 608.1741 [18-19] Chrysoeriol 7-O-neohesperidoside- 4′-glucoside C34H42O20 770.2269 [18-19,21,24-25] Chrysoeriol 8-C-glucoside Scoparin C22H22O11 462.1162 [25] Chrysoeriol-O-glucoside/Diosmetin-O-glucoside C22H22O11 462.1162 [9,20] Citric acid C6H8O7 192.0270 [23] Citropten C11H10O4 206.0579 [9,15,17-21,23-25] Diosmetin-6,8-di-C-glucoside Lucenin-2 4'-methyl ether C28H32O16 624.1690 [23] Deacetyl nomilin glucoside C32H44O14 652.2731 [23] Deacetyl nomilinic acid glucoside C32H46O15 670.2837 [25] Demethoxycentaureidin-7-O-β-glucoside C23H24O12 492.1268 [25] Demethoxycentaureidin-7-O-β-glucoside-HMG C29H32O16 636.1690 [21] Di-acetyl Caffeic acid C13H12O6 264.0634 [9,15-16,18-21,23-25] Diosmetin 7-O-neohesperidoside Neodiosmin C28H32O15 608.1741 [9,15,17-19,23-25] Diosmetin 8-C-glucoside Orientin 4' methylether C22H22O11 462.1162 [17] Diosmetin mono-rhamnoside C22H22O10 446.1213 [16-17,24] Diosmetin-7-O-glucoside C22H22O11 462.1162 [16,24] Diosmetin-7-O-neohesperidoside-6''-O-HMG C34H40O19 752.2164 [16] Diosmetin-7-O-rutinoside Diosmin C28H32O15 608.1741 [15] Diosmetin C16H12O6 300.0634 [9,15,17,19,21-23,25] Eriodictyol 7-O-rutinoside Eriocitrin C27H32O15 596.1741 [9,15-25] Eriodictyol 7-O-neohesperidoside Neoeriocitrin C27H32O15 596.1741 [17] Eriodictyol mono-rhamnoside C21H22O10 434.1213 [9,16,20-22,24] Eriodictyol-7-O-neohesperidoside-6”-O-HMG Neoeriocitrin-O-HMG C33H40O19 740.2164 [9] Eriodictyol-7-O-neohesperidoside-6”-O-HMG-glucoside C39H50O24 902.2692 [25] eriodictyol-7-O-β-glucoside C21H22O11 450.1162 [22,25] Eriodyctiol C15H12O6 288.0634 [21,23] Ferulic acid 4-O-glucoside C16H20O9 356.1107 [23] Heptamethoxyflavone C22H24O9 432.1420 [15,22,25] Hesperetin C16H14O6 302.0790 [9,15-25] Hesperetin-7-O-neohesperidoside Neohesperidin C28H34O15 610.1898 [17] hesperetin mono-rhamnoside C22H24O10 448.1369 [16,24] Hesperetin-7-O-glucoside-6''-O-HMG C28H32O15 608.1741 [15,22] Hesperetin-7-O-rutinoside Hesperidin C28H34O15 610.1898 [16,24-25] Hesperetin-7-O-β-glucoside C22H24O11 464.1319 [9] Hesperetin-7-O-neohesperidoside-6''-O-HMG-glucoside Neohesperidin-O-HMG glucoside C40H52O24 916.2848 [23] Ichangin C26H32O9 488.2046 [22] Isosakuranetin C16H14O5 286.0841 [22] Isosakuranetin-7-O-neohesperidoside-6”-O-HMG Parmigin C34H42O18 738.2371 [22] Isosakuranetin-7-O-rutinoside Didymin C28H34O14 594.1949 [15,23] Isosakuranetin-7-neohesperidoside Poncirin C28H34O14 594.1949 [23] Kaempferol 3-O-xylosyl-glucoside C26H28O15 580.1428 [9,23,25] Limonin C26H30O8 470.1941 [20,23] Limonin glucoside C32H42O14 650.2574 [16] Luteolin C15H10O6 286.0477 [21] Luteolin-8-C-glucoside Orientin C21H20O11 448.1006 [18-19,21,24-25] Luteolin 6,8-di-C-glucoside Lucenin-2 C27H30O16 610.1534 [9,16,24-25] Luteolin-7-O-neohesperidoside C27H30O15 594.1585 C21H20O11/C21H20 Luteolin mono-glucoside/monorhamnoside 448.10056/432.10564 [17] O10 [9,15-16,20-25] Naringenin 7-O-neohesperidoside-6''-O-HMG Melitidin C33H40O18 724.2215 [15,22,25] Naringenin C15H12O5 272.0685 [9,15-25] Naringenin 7-O-neohesperidoside Naringin C27H32O14 580.1792 [17] Naringenin mono-rhamnoside C21H22O9 418.1264 [16,22,24] Naringenin-7-O-glucoside-6”-O-HMG C27H30O14 578.1636 [15,17,22-23,25] Naringenin-7-O-rutinoside Narirutin C27H32O14 578.1636 [25] Naringenin-7-O-β-glucopyranoside Prunasin C21H22O10 434.1213 [25] Naringin-4′-O-β-glucopyranoside C33H42O19 742.2320 [23] Nobiletin C21H22O8 402.1315 [23] Nomilin C28H34O9 514.2203 [23] Nomilin glucoside C34H46O15 694.2837 [9,25] Nomilinic acid C28H36O10 532.2308 [9,20,23,25] Nomilinic acid glucoside C34H48O16 712.2942 [23] Obacunone glucoside C32H42O13 634.2625 [15] Quercetin-3-b-glucopyranoside Isoquercitrin C21H20O12 464.0955 [25] Quercetin rutinoside Rutin C27H30O16 610.1534 [21,23] Sinapoyl glucose C17H22O10 386.1213 [23,25] Sinensetin C20H20O7 372.1209 [23,25] Tangeretin C20H20O7 372.1209 [23] Tetra-O-methylscutellarein C19H18O6 342.1103 [25] Umbelliferone glucoside C15H16O8 324.0845 [23] Verbascoside C29H36O15 624.2054 [23] α-Limonol or Obacunoic acid C26H32O8 472.2097 S1. Method validation The major flavonoids (neoeriocitrin, naringin, neohesperidin, melitidin, and brutieridin) present in bergamot extracts were determined by chromatographic analysis with an HPLC system equipped with a DAD detector. Since the HPLC method was calibrated using naringin as standard, their concentration is expressed as naringin equivalent (mg/g extract). The calibration curve of naringenin was built in the range 12-300 mg/g extract by plotting the peak area of naringin versus the nominal concentrations by weighted (1/x2) least-squares linear regression: y=1574(±25.65)x – 10551(±3898), r2=0.9989. The concentration 12 mg/g was considered as the LLOQ because the precision (CV%) and accuracy (bias %) were lower than ±20%: +2.9 % and +17.1%, for CV% and bias % respectively. The precision and accuracy were calculated on five replicates of 3 concentrations: for the LLOQ the CV% and bias % were reported above, the precision and accuracy for the concentration 80 mg/g were +4.7% and -8.6%, and for the concentration 300 mg/g they were +2.2% and -0.4%, respectively. The method was considered selective because no peak of analyte was present at the same retention time of the analytes in 6 different blank samples. Figure S1. Quinic acid: C7H12O6 m/z 191.0564. MS/MS: m/z 147, 133. Found in MoNa and HMDB databases. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S2. HMG-O-glucoside: C12H20O10 m/z 323.0974. MS/MS: m/z 263, 179, 161, 125. Structure hypothesized through the mass losses and confirmed by the Peak assignment tool of CFM-ID Figure S3. 6-(beta-D-glucopyranosyloxy)-5-benzofuranpropanoic acid: C17H20O9 m/z 367.1028. MS/MS: m/z 205, 161. Found through the Spectra Similarity Search of MoNa database. Figure S4. 6-(beta-D-glucopyranosyloxy)-4-methoxy-5-benzofuranpropanoic acid: C18H22O10 m/z 397.1135. MS/MS: m/z 235, 191. Found in MoNa database. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S5. 6-hydroxy-4-methoxy-5-benzofuranpropanoic acid: C12H12O5 m/z 235.0611. MS/MS: m/z 191, 176. Hypothesized to be the aglycone of 6-(beta-D-glucopyranosyloxy)-4-methoxy-5- benzofuranpropanoic acid. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S6. Bergaptol: C11H6O4 m/z 201.0194. MS/MS: m/z 157. Found in HMDB database. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S7. Deacetylnomilinic acid: C26H34O9 m/z 489.2125. MS/MS: m/z 411, 333, 325. Found in HMDB database. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S8. Limonoate A-ring lactone: C26H32O9 m/z 487.1953. MS/MS: m/z 427, 383. Found in PubChem database. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S9. Deacetylnomilin: C26H32O8 m/z 471.2015. MS/MS: m/z 409, 325, 307. Found in HMDB database. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S10. p-coumaric acid: C9H8O3 m/z 163.0406. MS/MS: m/z 119. Found in MoNa and HMDB databases. Fragmentation confirmed by the Peak assignment tool of CFM-ID. Figure S11. 3-[2,4,5-trihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]propanoic acid: C14H18O5 m/z 265.1072. MS/MS: m/z 221, 203, 185, 177, 163, 151, 87. Found a similar structure (3-[3,4-dihydroxy-5- (3-methylbut-2-en-1-yl)phenyl]-2-hydroxypropanoic acid) through the Compound identification tool of CFM-ID. A different position of the hydroxy moiety was supposed on the base of the possibility that this structure could derive from the opening of a coumarin or the prenylation of the phenyl- propanoic acid. The Peak Assignment tool of CFM-ID confirm an optimum match between the experimental an the in silico generated spectra. Figure S12. Neoeriocitrin-O-glucoside/eriocitrin-O-glucoside: C33H42O20 m/z 757.2160. MS/MS: m/z 595, 449, 287. Structure hypothesized through the mass losses and confirmed by the Peak assignment tool of CFM-ID. Figure S13. Luteolin-O-neohesperidoside-O-glucoside: C33H40O20 m/z 755.2001. MS/MS: m/z 593, 447, 285. Structure hypothesized through the mass losses and confirmed by the Peak assignment tool of CFM-ID. Figure S14. Luteolin-C-glucoside-O-rhamnoside: C27H30O15 m/z 593.1502. MS/MS: m/z 473, 447, 285. Structure hypothesized through the mass losses and confirmed by the Peak assignment tool of CFM- ID.
Load more

Recommended publications
  • Chemical Profiles and Simultaneous Quantification of Aurantii Fructus By
    molecules Article Chemical Profiles and Simultaneous Quantification of Aurantii fructus by Use of HPLC-Q-TOF-MS Combined with GC-MS and HPLC Methods Yingjie He 1,2,† ID , Zongkai Li 3,†, Wei Wang 2, Suren R. Sooranna 4 ID , Yiting Shi 2, Yun Chen 2, Changqiao Wu 2, Jianguo Zeng 1,2, Qi Tang 1,2,* and Hongqi Xie 1,2,* 1 Hunan Key Laboratory of Traditional Chinese Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China; [email protected] (Y.H.); [email protected] (J.Z.) 2 National and Local Union Engineering Research Center for the Veterinary Herbal Medicine Resources and Initiative, Hunan Agricultural University, Changsha 410128, China; [email protected] (W.W.); [email protected] (Y.S.); [email protected] (Y.C.); [email protected] (C.W.) 3 School of Medicine, Guangxi University of Science and Technology, Liuzhou 565006, China; [email protected] 4 Department of Surgery and Cancer, Chelsea and Westminster Hospital, Imperial College London, London SW10 9NH, UK; [email protected] * Correspondence: [email protected] (Q.T.); [email protected] (H.X.); Fax: +86-0731-8461-5293 (H.X.) † These authors contributed equally to this work. Received: 1 August 2018; Accepted: 29 August 2018; Published: 30 August 2018 Abstract: Aurantii fructus (AF) is a traditional Chinese medicine that has been used to improve gastrointestinal motility disorders for over a thousand years, but there is no exhaustive identification of the basic chemical components and comprehensive quality control of this herb. In this study, high-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (HPLC-Q-TOF-MS) and gas chromatography coupled mass spectrometry (GC-MS) were employed to identify the basic chemical compounds, and high-performance liquid chromatography (HPLC) was developed to determine the major biochemical markers from AF extract.
    [Show full text]
  • Mechanisms of Toxic Action of the Flavonoid Quercetin and Its Phase II Metabolites
    Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Promotor: Prof. Dr. Ir. I.M.C.M. Rietjens Hoogleraar in de Toxicologie Wageningen Universiteit Co-promotor: Dr. G.M. Alink Universitair Hoofddocent, Sectie Toxicologie Wageningen Universiteit. Promotiecommissie: Prof. Dr. A. Bast Universiteit Maastricht Dr. Ir. P.C.H. Hollman RIKILT Instituut voor Voedselveiligheid, Wageningen Prof. Dr. Ir. F.J. Kok Wageningen Universiteit Prof. Dr. T. Walle Medical University of South Carolina, Charleston, SC, USA Dit onderzoek is uitgevoerd binnen de onderzoekschool VLAG Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Proefschrift ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. Dr. M.J. Kropff, in het openbaar te verdedigen op vrijdag 7 april 2006 des namiddags te half twee in de Aula Title Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Author Hester van der Woude Thesis Wageningen University, Wageningen, the Netherlands (2006) with abstract, with references, with summary in Dutch. ISBN 90-8504-349-2 Abstract During and after absorption in the intestine, quercetin is extensively metabolised by the phase II biotransformation system. Because the biological activity of flavonoids is dependent on the number and position of free hydroxyl groups, a first objective of this thesis was to investigate the consequences of phase II metabolism of quercetin for its biological activity. For this purpose, a set of analysis methods comprising HPLC-DAD, LC-MS and 1H NMR proved to be a useful tool in the identification of the phase II metabolite pattern of quercetin in various biological systems.
    [Show full text]
  • Shilin Yang Doctor of Philosophy
    PHYTOCHEMICAL STUDIES OF ARTEMISIA ANNUA L. THESIS Presented by SHILIN YANG For the Degree of DOCTOR OF PHILOSOPHY of the UNIVERSITY OF LONDON DEPARTMENT OF PHARMACOGNOSY THE SCHOOL OF PHARMACY THE UNIVERSITY OF LONDON BRUNSWICK SQUARE, LONDON WC1N 1AX ProQuest Number: U063742 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U063742 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENT I wish to express my sincere gratitude to Professor J.D. Phillipson and Dr. M.J.O’Neill for their supervision throughout the course of studies. I would especially like to thank Dr. M.F.Roberts for her great help. I like to thank Dr. K.C.S.C.Liu and B.C.Homeyer for their great help. My sincere thanks to Mrs.J.B.Hallsworth for her help. I am very grateful to the staff of the MS Spectroscopy Unit and NMR Unit of the School of Pharmacy, and the staff of the NMR Unit, King’s College, University of London, for running the MS and NMR spectra.
    [Show full text]
  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine
    [Show full text]
  • Phenolic Profiling of Veronica Spp. Grown in Mountain, Urban and Sand Soil Environments
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Biblioteca Digital do IPB Phenolic profiling of Veronica spp. grown in mountain, urban and sand soil environments João C.M. Barreiraa,b,c, Maria Inês Diasa,c, Jelena Živkovićd, Dejan Stojkoviće, Marina Sokoviće, Celestino Santos-Buelgab,*, Isabel C.F.R. Ferreiraa,* aCIMO/Escola Superior Agrária, Instituto Politécnico de Bragança, Apartado 1172, 5301-855 Bragança, Portugal. bGIP-USAL, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain. cREQUIMTE/Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. dInstitute for Medicinal Plant Research “Dr. Josif Pančić”, Tadeuša Košćuška 1, 11000 Belgrade, Serbia. eDepartment of Plant Physiology, Institute for Biological Research “Siniša Stanković”, University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia. * Authors to whom correspondence should be addressed (Isabel C.F.R. Ferreira; e-mail: [email protected], telephone +351273303219, fax +351273325405; e-mail: Celestino Santos- Buelga: [email protected]; telephone +34923294537; fax +34923294515). 1 Abstract Veronica (Plantaginaceae) genus is widely distributed in different habitats. Phytochemistry studies are increasing because most metabolites with pharmacological interest are obtained from plants. The phenolic compounds of V. montana, V. polita and V. spuria were tentatively identified by HPLC-DAD-ESI/MS. The phenolic profiles showed that flavones were the major compounds (V. montana: 7 phenolic acids, 5 flavones, 4 phenylethanoids and 1 isoflavone; V. polita: 10 flavones, 5 phenolic acids, 2 phenylethanoids, 1 flavonol and 1 isoflavone; V. spuria: 10 phenolic acids, 5 flavones, 2 flavonols, 2 phenylethanoids and 1 isoflavone), despite the overall predominance of flavones.
    [Show full text]
  • Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study
    RESEARCH ARTICLE Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study Konstantinos M. Kasiotis1*, Pelagia Anastasiadou1, Antonis Papadopoulos2, Kyriaki Machera1* 1 Benaki Phytopathological Institute, Department of Pesticides Control and Phytopharmacy, Laboratory of Pesticides' Toxicology, Kifissia, Athens, Greece, 2 Benaki Phytopathological Institute, Department of Phytopathology, Laboratory of Non-Parasitic Diseases, Kifissia, Athens, Greece * [email protected] (KMK); [email protected] (KM) Abstract a1111111111 Propolis is a bee product that has been extensively used in alternative medicine and recently a1111111111 a1111111111 has gained interest on a global scale as an essential ingredient of healthy foods and cosmet- a1111111111 ics. Propolis is also considered to improve human health and to prevent diseases such as a1111111111 inflammation, heart disease, diabetes and even cancer. However, the claimed effects are anticipated to be correlated to its chemical composition. Since propolis is a natural product, its composition is consequently expected to be variable depending on the local flora align- ment. In this work, we present the development of a novel HPLC-PDA-ESI/MS targeted OPEN ACCESS method, used to identify and quantify 59 phenolic compounds in Greek propolis hydroalco- holic extracts. Amongst them, nine phenolic compounds are herein reported for the first time Citation: Kasiotis KM, Anastasiadou P, Papadopoulos A, Machera K (2017) Revisiting in Greek propolis. Alongside GC-MS complementary analysis was employed, unveiling Greek Propolis: Chromatographic Analysis and eight additional newly reported compounds. The antioxidant activity study of the propolis Antioxidant Activity Study. PLoS ONE 12(1): samples verified the potential of these extracts to effectively scavenge radicals, with the e0170077. doi:10.1371/journal.pone.0170077 extract of Imathia region exhibiting comparable antioxidant activity to that of quercetin.
    [Show full text]
  • Distribution of Flavonoids Among Malvaceae Family Members – a Review
    Distribution of flavonoids among Malvaceae family members – A review Vellingiri Vadivel, Sridharan Sriram, Pemaiah Brindha Centre for Advanced Research in Indian System of Medicine (CARISM), SASTRA University, Thanjavur, Tamil Nadu, India Abstract Since ancient times, Malvaceae family plant members are distributed worldwide and have been used as a folk remedy for the treatment of skin diseases, as an antifertility agent, antiseptic, and carminative. Some compounds isolated from Malvaceae members such as flavonoids, phenolic acids, and polysaccharides are considered responsible for these activities. Although the flavonoid profiles of several Malvaceae family members are REVIEW REVIEW ARTICLE investigated, the information is scattered. To understand the chemical variability and chemotaxonomic relationship among Malvaceae family members summation of their phytochemical nature is essential. Hence, this review aims to summarize the distribution of flavonoids in species of genera namely Abelmoschus, Abroma, Abutilon, Bombax, Duboscia, Gossypium, Hibiscus, Helicteres, Herissantia, Kitaibelia, Lavatera, Malva, Pavonia, Sida, Theobroma, and Thespesia, Urena, In general, flavonols are represented by glycosides of quercetin, kaempferol, myricetin, herbacetin, gossypetin, and hibiscetin. However, flavonols and flavones with additional OH groups at the C-8 A ring and/or the C-5′ B ring positions are characteristic of this family, demonstrating chemotaxonomic significance. Key words: Flavones, flavonoids, flavonols, glycosides, Malvaceae, phytochemicals INTRODUCTION connate at least at their bases, but often forming a tube around the pistils. The pistils are composed of two to many connate he Malvaceae is a family of flowering carpels. The ovary is superior, with axial placentation, with plants estimated to contain 243 genera capitate or lobed stigma. The flowers have nectaries made with more than 4225 species.
    [Show full text]
  • BIOLOGICAL PROPERTIES of SELECTED FLAVONOIDS of ROOIBOS (Aspalathus Linearis)
    BIOLOGICAL PROPERTIES OF SELECTED FLAVONOIDS OF ROOIBOS (Aspalathus linearis) Petra W Snijman Thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Chemistry at the University of the Western Cape Study Leader: Prof IR Green Co-study Leaders: Prof E Joubert Prof WCA Gelderblom June 2007 ii DECLARATION I, the undersigned, hereby declare that the work contained in this thesis is my own original work and that I have not previously in its entirety or in part submitted it at any university for a degree. _______________________________ ____________ Petra Wilhelmina Snijman Date Copyright © 2007 University of the Western Cape All rights reserved iii ABSTRACT Bioactivity-guided fractionation was used to identify the most potent antioxidant and antimutagenic fractions contained in the methanol extract of unfermented rooibos (Aspalathus linearis), as well as the bioactive principles for the most potent antioxidant fractions. The different extracts and fractions were screened using Salmonella typhimurium tester strain TA98 and metabolically activated 2- acetoaminofluorene (2-AAF) to evaluate antimutagenic potential, while the antioxidant potency was assessed by two different in vitro assays, i.e. the inhibition of Fe(II) induced microsomal lipid peroxidation and the scavenging of the 2,2'- azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical cation. The most polar XAD fraction displayed the most protection against 2-AAF induced mutagenesis in TA98. Successive fractionation of the two XAD fractions
    [Show full text]
  • Phytochemical Studies of the Moss Species Plagiomnium Elatum and Plagiomnium Cuspidatum
    journ. Hattori Bot. Lab. No. 67: 377- 382 (Dec. 1989) PHYTOCHEMICAL STUDIES OF THE MOSS SPECIES PLAGIOMNIUM ELATUM AND PLAGIOMNIUM CUSPIDATUM 1 S. ANHUT , T. SEEGER 1, J. B IEHL 1 , H. D . ZINSMEISTER 1 AND H . GEIGER 2 ABSTRACT. The flavonoid pattern of P/agiomnium cuspidatum and P. e/atum was evaluated. Fifteen dif­ ferent flavones, mainly flavone glycosides were isolated. The new natural compounds Elatin; 5-0H-Amento­ flavone; 2,3-Dihydro-5' -hydroxyamentoflavone, 2,3-Dihydro-5' -hydroxyrobustaflavone and 2,3-Dihydro- 5',3"'-dihydroxyamentoflavone were amongst them. The phytochemical relevance of these results is briefly discussed. INTRODUCTION The fi rst phytochemical studies on Mnium species was done by Kozlowski (1921). He detected Saponarin in Mnium cu:,pidatum, based on a chemical reaction with iodinepotassium iodide solution. Melchert & Alston (1965) reported on the occurrence of flavon C-glycosides in Mnium affine, McClure and Miller (1967) offlavonoids in Mnium cu.lpidatum. Koponen and Nilsson (1977) compared the flavonoid patterns of Plagiomnium elfipticum, P. medium, P. insigne, P. affine, P. tezukae, P. ciliare, P. ela/um, P. drummondii, P. japonicum, P. acutum and P. cuspidatum. Vandekerkhove (1977) isolated two f1avonoids from Mnium undulatum and characterized them as saponarin and an apigenin-6,8 di-C-glycoside. Further C- and C-O-glycosides from the same species were isolated and identified by Osterdahl (1979). Freitag et at. (1986) isolated two new isoorientin-O-diglycosides from P. affine. According to the "Generic revision of Mniaceae" (Koponen, 1968) all mentioned species were allocated to the genus Plagiomnium. The revised classification of the family Mniaceae resulted in four tribes with ten genera on the basis of morphological and karyological data.
    [Show full text]
  • Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4
    ORIGINAL SCIENTIFIC PAPER Croat. Chem. Acta 2020, 93(1), 33–39 Published online: August 03, 2020 DOI: 10.5562/cca3652 Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4 Martin Kondža,1 Hrvoje Rimac,2,3 Željan Maleš,4 Petra Turčić,5 Ivan Ćavar,6 Mirza Bojić2,* 1 University of Mostar, Faculty of Pharmacy, Matice hrvatske bb, 88000 Mostar, Bosnia and Herzegovina 2 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, 10000 Zagreb, Croatia 3 South Ural State University, Higher Medical and Biological School, Laboratory of Computational Modeling of Drugs, 454000 Chelyabinsk, Russian Federation 4 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Botany, Schrottova 39, 10000 Zagreb, Croatia 5 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmacology, Domagojeva 2, 10000 Zagreb, Croatia 6 University of Mostar, Faculty of Medicine, Kralja Petra Krešimira IV bb, 88000 Mostar, Bosnia and Herzegovina * Corresponding author’s e-mail address: [email protected] RECEIVED: June 26, 2020 REVISED: July 28, 2020 ACCEPTED: July 30, 2020 Abstract: Cytochrome P450 3A4 is the most significant enzyme in metabolism of medications. Flavonoids are common secondary plant metabolites found in fruits and vegetables. Some flavonoids can interact with other drugs by inhibiting cytochrome P450 enzymes. Thus, the objective of this study was to determine inhibition kinetics of cytochrome P450 3A4 by flavonoids: acacetin, apigenin, chrysin and pinocembrin. For this purpose, testosterone was used as marker substrate, and generation of the 6β-hydroxy metabolite was monitored by high performance liquid chromatography coupled with diode array detector.
    [Show full text]
  • Cphi & P-MEC China Exhibition List展商名单version版本20180116
    CPhI & P-MEC China Exhibition List展商名单 Version版本 20180116 Booth/ Company Name/公司中英文名 Product/产品 展位号 Carbosynth Ltd E1A01 Toronto Research Chemicals Inc E1A08 SiliCycle Inc. E1A10 SA TOURNAIRE E1A11 Indena SpA E1A17 Trifarma E1A21 LLC Velpharma E1A25 Anuh Pharma E1A31 Chemclone Industries E1A51 Hetero Labs Limited E1B09 Concord Biotech Limited E1B10 ScinoPharm Taiwan Ltd E1B11 Dongkook Pharmaceutical Co., Ltd. E1B19 Shenzhen Salubris Pharmaceuticals Co., Ltd E1B22 GfM mbH E1B25 Leawell International Ltd E1B28 DCS Pharma AG E1B31 Agno Pharma E1B32 Newchem Spa E1B35 APEX HEALTHCARE LIMITED E1B51 AMRI E1C21 Aarti Drugs Limited E1C25 Espee Group Innovators E1C31 Ruland Chemical Co., Ltd. E1C32 Merck Chemicals (Shanghai) Co., Ltd. E1C51 Mediking Pharmaceutical Group Ltd E1C57 珠海联邦制药股份有限公司/The United E1D01 Laboratories International Holdings Ltd. FMC Corporation E1D02 Kingchem (Liaoning) Chemical Co., Ltd E1D10 Doosan Corporation E1D22 Sunasia Co., Ltd. E1D25 Bolon Pharmachem Co., Ltd. E1D26 Savior Lifetec Corporation E1D27 Alchem International Pvt Ltd E1D31 Polish Investment and Trade Agency E1D57 Fischer Chemicals AG E1E01 NGL Fine Chem Limited E1E24 常州艾柯轧辊有限公司/ECCO Roller E1E25 Linnea SA E1E26 Everlight Chemical Industrial Corporation E1E27 HARMAN FINOCHEM E1E28 Zhechem Co Ltd E1F01 Midas Pharma GmbH Shanghai Representativ E1F03 Supriya Lifescience Ltd E1F10 KOA Shoji Co Ltd E1F22 NOF Corporation E1F24 上海贺利氏工业技术材料有限公司/Heraeus E1F26 Materials Technology Shanghai Ltd. Novacyl Asia Pacific Ltd E1F28 PharmSol Europe Limited E1F32 Bachem AG E1F35 Louston International Inc. E1F51 High Science Co Ltd E1F55 Chemsphere Technology Inc. E1F57a PharmaCore Biotech Co., Ltd. E1F57b Rockwood Lithium GmbH E1G51 Sarv Bio Labs Pvt Ltd E1G57 抗病毒类、抗肿瘤类、抗感染类和甾体类中间体、原料药和药物制剂及医药合约研发和加工服务 上海创诺医药集团有限公司/Shanghai Desano APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and E1H01 Pharmaceuticals Co., Ltd.
    [Show full text]
  • Review Article Interactions Between CYP3A4 and Dietary Polyphenols
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2015, Article ID 854015, 15 pages http://dx.doi.org/10.1155/2015/854015 Review Article Interactions between CYP3A4 and Dietary Polyphenols Loai Basheer and Zohar Kerem Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, P.O. Box 12, 76100 Rehovot, Israel Correspondence should be addressed to Zohar Kerem; [email protected] Received 14 October 2014; Revised 15 December 2014; Accepted 19 December 2014 Academic Editor: Cristina Angeloni Copyright © 2015 L. Basheer and Z. Kerem. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ThehumancytochromeP450enzymes(P450s)catalyzeoxidativereactionsofabroadspectrumofsubstratesandplayacritical role in the metabolism of xenobiotics, such as drugs and dietary compounds. CYP3A4 is known to be the main enzyme involved in the metabolism of drugs and most other xenobiotics. Dietary compounds, of which polyphenolics are the most studied, have been shown to interact with CYP3A4 and alter its expression and activity. Traditionally, the liver was considered the prime site of CYP3A-mediated first-pass metabolic extraction, but in vitro and in vivo studies now suggest that the small intestine can be of equal or even greater importance for the metabolism of polyphenolics and drugs. Recent studies have pointed to the role of gut microbiota in the metabolic fate of polyphenolics in human, suggesting their involvement in the complex interactions between dietary polyphenols and CYP3A4.
    [Show full text]